Invited review: Historical review of BCG vaccine in Japan

DOI Web Site Web Site 被引用文献7件
  • Yamamoto Saburo
    Department of Microbial and Molecular Pathogenesis, Texas A&M University Health Science Center, College of Medicine, USA Ex Laboratory of Tuberculosis Control, Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases, Japan
  • Yamamoto Toshiko
    Department of Microbial and Molecular Pathogenesis, Texas A&M University Health Science Center, College of Medicine, USA

書誌事項

タイトル別名
  • Historical Review of BCG Vaccine in Japan

この論文をさがす

説明

<p>Bacillus Calmette and Guérin (BCG) was introduced to Japan in 1924 by Kiyoshi Shiga and has been propagated for research purposes ever since propagation is accomplished using a glycerin-bile-potato mixture in the same manner used by Calmette and Guérin. To prepare a stable and safe freeze-dried BCG vaccine, several joint research projects were organized in 1949. At the National Institute of Infectious Diseases (formerly the National Institute of Health), the 172nd passage of BCG from the first culture was freeze-dried in 1961 and was used as the origin of the Japanese BCG strain, Tokyo-172. The Tokyo-172 was registered as an International Reference Strain in 1965 by the World Health Organization. In 1967, a multiple puncture method for BCG vaccination using a plastic cylinder implanted with nine fine needles at one end was introduced to Japan; there-after, percutaneous administration replaced intradermal injection. The efficacy and adverse reactions of BCG vaccines as well as recent knowledge on the genetic characterization of BCG is also discussed.</p>

収録刊行物

被引用文献 (7)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ